Population pharmacokinetic modeling of ustekinumab, a human monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque psoriasis.

Source:http://linkedlifedata.com/resource/pubmed/id/19179295

Download in:

View as

General Info

PMID
19179295